Suzhou, China

Weiwei Wu

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Innovent Biologics (Suzhou) Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Weiwei Wu. Retrieved from https://idiyas.com/inventor/weiwei-wu-asuwpxuj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

0

Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Weiwei Wu and Her Patent in Biopharmaceutical Innovation.

Introduction

Weiwei Wu is an inventor associated with Suzhou, China, and Innovent Biologics (Suzhou) Co., Ltd. Her patent activity includes work related to interleukin-2, a protein involved in immune-system signaling.

Latest Patents

Wu is listed as an inventor on one patent: “Interleukin-2 Mutant and Fusion Protein Thereof.” The patent concerns an interleukin-2 mutant and a fusion protein incorporating it. Her record includes 1 patent.

Career Highlights

Wu’s listed patent connects her inventive work with biopharmaceutical research at Innovent Biologics (Suzhou) Co., Ltd. The patent’s subject matter reflects research into engineered proteins with potential relevance to therapeutic development.

Collaborations

Wu’s listed coworkers include Kaijie He and Fenggen Fu, who are also associated with the patent.

Conclusion

Weiwei Wu’s patent record highlights her contribution to biopharmaceutical innovation through work on an interleukin-2 mutant and its fusion protein.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…